Is Perspective Therapeutics Inc. (CATX) undervalued? · rev $2.2M
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
This page asks whether Perspective Therapeutics Inc. (CATX) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported CATX revenue for 2023-09-30 was $2.2M. Net income was -$10.4M. Revenue was up 4.6% from 2023-06-30 to 2023-09-30. CATX currently screens at market cap $280.6M.
CATX currently screens at market cap $280.6M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new CATX 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare CATX to the stock page model before you treat a low multiple as a gift.
Not investment advice.